Takeda’s Pharmaceutical Development Division has entered into strategic partnerships with Covance and Quintiles to plan and execute global development programs to support new compounds in all therapeutic areas, except oncology. Takeda will have access to Covance and Quintiles clinical development capabilities and central lab services, with each partner providing resources to support Takeda’s development pipeline. Takeda plans to use a global program-level sourcing strategy to increase operati...